JIN Ptb Ratio from 2010 to 2025

ZJYL Stock   0.77  0.04  5.48%   
JIN MEDICAL PTB Ratio yearly trend continues to be quite stable with very little volatility. PTB Ratio may rise above 13.80 this year. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on JIN MEDICAL's equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
13.14
Current Value
13.8
Quarterly Volatility
7.50001758
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check JIN MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JIN MEDICAL's main balance sheet or income statement drivers, such as Depreciation And Amortization of 377 K, Interest Expense of 8.1 K or Selling General Administrative of 2.2 M, as well as many indicators such as Price To Sales Ratio of 16.92, Dividend Yield of 0.0 or PTB Ratio of 13.8. JIN financial statements analysis is a perfect complement when working with JIN MEDICAL Valuation or Volatility modules.
  
Check out the analysis of JIN MEDICAL Correlation against competitors.

Latest JIN MEDICAL's Ptb Ratio Growth Pattern

Below is the plot of the Ptb Ratio of JIN MEDICAL INTERNATIONAL over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. JIN MEDICAL's PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in JIN MEDICAL's overall financial position and show how it may be relating to other accounts over time.
Ptb Ratio10 Years Trend
Slightly volatile
   Ptb Ratio   
       Timeline  

JIN Ptb Ratio Regression Statistics

Arithmetic Mean11.94
Geometric Mean5.52
Coefficient Of Variation62.84
Mean Deviation6.45
Median17.66
Standard Deviation7.50
Sample Variance56.25
Range17.4558
R-Value(0.49)
Mean Square Error45.82
R-Squared0.24
Significance0.05
Slope(0.77)
Total Sum of Squares843.75

JIN Ptb Ratio History

2025 13.8
2024 13.14
2023 14.6
2022 7.08
2021 0.21
2020 0.23
2019 0.29

About JIN MEDICAL Financial Statements

JIN MEDICAL investors utilize fundamental indicators, such as Ptb Ratio, to predict how JIN Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
PTB Ratio 13.14  13.80 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out the analysis of JIN MEDICAL Correlation against competitors.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.676
Earnings Share
0.02
Revenue Per Share
0.15
Quarterly Revenue Growth
0.353
Return On Assets
0.0578
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.